Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

NCT00158990Phase 3Completed
Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
Bipolar DisorderMajor DepressionUnipolar Depression
Principalinvestigator
NCT00885222Not ApplicableCompleted
Antidepressant Effect of Deep Brain Stimulation in Parkinson's Disease Patients
Major Depressive DisorderParkinson's Disease
Studychair

Research Network

Collaboration Network

7 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Carlos A Zarate, M.D.

National Institute of Mental Health (NIMH)

Related
19 trials

Shared therapeutic areas:

Major Depressive DisorderMajor DepressionBipolar Disorder+2 more
Similarity Score25%

Zvi Israel, MD

Hadassah Medical Organization

Related
2 trials

Shared therapeutic areas:

Parkinson DiseaseMajor Depressive Disorder

Worked with same sponsors:

Hadassah Medical Organization
Collaborated on 1 trial
Similarity Score24%

Renana Eitan, MD

Hadassah Medical Organization

Related
5 trials

Shared therapeutic areas:

Parkinson DiseaseMajor Depressive Disorder

Worked with same sponsors:

Hadassah Medical Organization
Collaborated on 1 trial
Similarity Score24%

Hagai Bergman, MD

Hadassah Medical Organization

Related
1 trials

Shared therapeutic areas:

Major Depressive DisorderParkinson Disease

Worked with same sponsors:

Hadassah Medical Organization
Collaborated on 1 trial
Similarity Score24%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Major DepressionMajor Depressive DisorderParkinson Disease+1 more
Similarity Score20%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Bipolar DisorderMajor Depressive DisorderParkinson Disease
Similarity Score15%

Charles Conway, MD

Washington University School of Medicine

Related
6 trials

Shared therapeutic areas:

Major Depressive DisorderUnipolar DepressionMajor Depression
Similarity Score15%

Urielle Desalbres

Assistance Publique HĂ´pitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Bipolar DisorderParkinson DiseaseSchizophrenia
Similarity Score15%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

SchizophreniaBipolar DisorderParkinson Disease
Similarity Score15%

Uriel Heresco-Levy, MD

Ezrath Nashim - Herzog Memorial Hospital

Related
1 trials

Shared therapeutic areas:

Schizophrenia

Worked with same sponsors:

Hadassah Medical OrganizationHerzog Hospital
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00158990Phase 3PrincipalInvestigator

Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.

Bipolar DisorderMajor DepressionUnipolar Depression
Completed
NCT00885222Not ApplicableStudyChair

Antidepressant Effect of Deep Brain Stimulation in Parkinson's Disease Patients

Major Depressive DisorderParkinson's Disease
Completed
NCT01459029Phase 2StudyDirector

High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia

Schizophrenia
Unknown

All 3 trials loaded